Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...

Biocodex obtained an exclusive worldwide license for Batten-1 and an exclusive US/Canada license for TX01, while THX Pharma retains leadership of clinical development for both assets. Total ...

THX Pharma, a biopharmaceutical company specializing in the development of innovative treatments for rare diseases and Biocodex, an independent international pharmaceutical group, announced the ...

Lyon, France – February 19, 2026, 6:00 p.m. CET – THX Pharma (Theranexus), an innovative biopharmaceutical company specializing in the treatment of rare neurological diseases, today announces the ...

Ryan Gosling made a rare comment about his and Eva Mendes' two daughters as he revealed they were 'very critical' of his new ...

THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing agreement to advance the development of two drug ...

In an era of rapid-fire ‘Thx’ and automated email replies, let's look back at a word that carries the weight of genuine ...

Over the past few years, I've been searching for the best audio option for my PC gaming setup. It’s been a battle. I have big, satellite-dish ears and the kind of Neurospicy that makes ear cushions ...